Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asasantin Retard versus clopidogrel for endothelial and inflammatory markers in type 2 diabetes with prior TIA or stroke
2006-006971-19Phase 4Completed
- Sponsor
- Aker Hospital
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dipyridamole + aspirin and clopidogrel in type 2 diabetes mellitus (T2DM), transient ischaemic attack (TIA) and stroke (2 arms), sponsored by Aker Hospital. Primary endpoint: Microalbuminuria. Started Nov 2008; status: completed.
02
Drugs
dipyridamole + aspirinclopidogrel
03
Conditions
type 2 diabetes mellitus (T2DM)transient ischaemic attack (TIA)stroke
Beyond the preview
Go deeper on 2006-006971-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006971-19.